CD44−/− mice were resistant to HCC induction using the hepatic procarcinogen diethylnitrosamine, and CD44 on murine hepatocytes is induced by carcinogen exposure and suppresses p53-mediated genomic surveillance via AKT and Mdm2 [148]. Here, CD44 is linked to hepatocellular carcinoma.